Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00709527
Brief Title: ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration

First Submitted : July 1, 2008
First Submitted that Met QC Criteria : July 2, 2008
First Posted : July 3, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : June 14, 2012
Last Update Posted : June 18, 2012 (Estimate)